Biogen (BIIB) Payables (2009 - 2026)
Biogen (BIIB) recorded Payables of $430.3 million in Q3 2026, up 4.2% from $413.1 million a year earlier and up 6.5% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen reported Payables of $432 million, down 80.1% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- Across earlier years, Payables came in at $2.17 billion in FY2024 (+292.7%), $553.3 million in FY2023 (+12.6%), $491.5 million in FY2022 (-69.1%) and $1.59 billion in FY2021 (+249.2%).
- Quarterly Payables has ranged from $354.5 million in Q2 2024 to $2.17 billion in Q4 2024 over the past five years.
- On a year-over-year basis, Payables rose in four of the last eight quarters, with growth averaging 37.8%.
- Peak year-over-year performance for Payables in the last five years was growth of 292.7% in Q4 2024, against a decline of 83.3% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $403.9 million (Q2 2026), $358.5 million (Q1 2026) and $432 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 430.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 430.30 Mn |
| Jun 30, 2026 | 403.90 Mn |
| Mar 31, 2026 | 358.50 Mn |
| Dec 31, 2025 | 432.00 Mn |
| Sep 30, 2025 | 413.10 Mn |
| Jun 30, 2025 | 408.40 Mn |
| Mar 31, 2025 | 2.14 Bn |
| Dec 31, 2024 | 2.17 Bn |
| Sep 30, 2024 | 2.17 Bn |
| Jun 30, 2024 | 354.50 Mn |
| Mar 31, 2024 | 637.00 Mn |
| Dec 31, 2023 | 553.30 Mn |
| Sep 30, 2023 | 940.10 Mn |
| Jun 30, 2023 | 445.40 Mn |
| Mar 31, 2023 | 491.20 Mn |
| Dec 31, 2022 | 491.50 Mn |
| Sep 30, 2022 | 383.20 Mn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.40 Bn |
| Dec 31, 2021 | 1.59 Bn |
API Access
Biogen Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();